Acetylation at lysine 346 controls the transforming activity of the HTLV-1 Tax oncoprotein in the Rat-1 fibroblast model by Julie Lodewick et al.
Lodewick et al. Retrovirology 2013, 10:75
http://www.retrovirology.com/content/10/1/75RESEARCH Open AccessAcetylation at lysine 346 controls the
transforming activity of the HTLV-1 Tax
oncoprotein in the Rat-1 fibroblast model
Julie Lodewick1, Carla Sampaio1,3, Mathieu Boxus2, Anne-Sophie Rinaldi1, Katia Coulonval3, Luc Willems2,
Pierre P Roger3 and Françoise Bex1*Abstract
Background: Transformation by the Tax oncoprotein of the human T cell leukemia virus type 1 (HTLV-1) is
governed by actions on cellular regulatory signals, including modulation of specific cellular gene expression via
activation of signaling pathways, acceleration of cell cycle progression via stimulation of cyclin-dependent kinase
activity leading to retinoblastoma protein (pRb) hyperphosphorylation and perturbation of survival signals. These
actions control early steps in T cell transformation and development of Adult T cell leukemia (ATL), an aggressive
malignancy of HTLV-1 infected T lymphocytes. Post-translational modifications of Tax by phosphorylation,
ubiquitination, sumoylation and acetylation have been implicated in Tax-mediated activation of the NF-κB pathway,
a key function associated with Tax transforming potential.
Results: In this study, we demonstrate that acetylation at lysine K346 in the carboxy-terminal domain of Tax is
modulated in the Tax nuclear bodies by the acetyltransferase p300 and the deacetylases HDAC5/7 and controls
phosphorylation of the tumor suppressor pRb by Tax-cyclin D3-CDK4-p21CIP complexes. This property correlates
with the inability of the acetylation deficient K346R mutant, but not the acetylation mimetic K346Q mutant, to
promote anchorage-independent growth of Rat-1 fibroblasts. By contrast, acetylation at lysine K346 had no effects
on the ability of Tax carboxy-terminal PDZ-binding domain to interact with the tumor suppressor hDLG.
Conclusions: The identification of the acetyltransferase p300 and the deacetylase HDAC7 as enzymes modulating
Tax acetylation points to new therapeutic targets for the treatment of HTLV-1 infected patients at risk of developing
ATL.
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The oncogenic retrovirus human T cell leukemia virus
type 1 (HTLV-1) causes both Adult T cell leukemia
(ATL), a fatal malignancy that occurs in 2 to 4% of
infected carriers after decades of asymptomatic infection,
and a neurodegenerative disease called HTLV-1 associated
myelopathy/tropical spastic paraparesis (HAM/TSP) [1-3].
Early steps in the transformation of CD4+ T lymphocytes
by HTLV-1 have been associated with the oncogenic
properties of its protein Tax.* Correspondence: fbex@ulb.ac.be
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reproduction in any medium, provided the orFour central activities have been linked to Tax
transforming potential. First, Tax activates cellular
signaling pathways, including the canonical [4-9] and
non-canonical NF-κB [10-13], the SRF [14-16] and the
AP1 [17,18] pathways. This activity determines the
expression of cellular genes involved in proliferation
and differentiation of T lymphocytes. Second, Tax com-
promises genome stability by modulating the timing of
replication origin activation and induction of reactive
oxygen species (ROS) leading to generation of double
strand breaks (DSB) [19,20]. In addition, Tax restricts
appropriate response to DNA damages and suppresses
apoptotic signals by inactivating the tumor suppressor
p53 [21-25]. Third, Tax activates the pRb kinase activityral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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hyperphosphorylation and proteasomal degradation. This
activity leads to the release of active E2F transcription
factor and acceleration of cell cycle progression at the G1
to S restriction point [26-30]. Fourth, Tax interacts with
PDZ domain-containing proteins, including the tumor
suppressors human homolog of Drosophila discs large
protein (hDLG), Scribbe (hScrib) and MAGI-1, via
its carboxy (C)-terminal PDZ binding motif (PBM)
E350TEV353. These interactions result in perturbation
of hDLG, hScrib and MAGI-1 functions in cell
growth control [31-36]. The contribution of each of these
oncogenic activities to Tax-mediated transforming pheno-
type and establishment of the leukemogenic process
remains debatable. In addition, the observations that Tax
expression is frequently turned off in leukemic T lympho-
cytes from ATL patients, and that the HTLV-1 bZIP factor
(HBZ) promotes proliferation of ATL cells through its
mRNA form, clouds the role of Tax in the maintenance of
the transformed state [37].
Post-translational modifications of Tax, in the form of
phosphorylation, poly-ubiquitination, and poly-sumoylation
control both Tax intracellular localization as well as
Tax-mediated activation of the NF-κB pathway [38-42].
This involves cooperation between phosphorylation
dependent poly-ubiquitinated cytoplasmic forms of Tax
and poly-sumoylated nuclear forms, resulting in the as-
sembly of transcriptionally active Tax nuclear bodies
(NBs) containing the RelA subunit of NF-κB and the tran-
scriptional coactivator p300 [43]. The contribution of both
ubiquitination and sumoylation in Tax-mediated activa-
tion of the NF-κB pathway has been recently challenged
[44] and further discussed [45,46].
Our group has previously reported that the lysine resi-
due at amino acid position 346 (previously designated
K10) in the C-terminal domain of Tax is the target for
acetylation by the acetyltransferase activity of p300.
Acetylation of Tax favors transcription initiated at a
chromatin-integrated, but not on a transiently transfected,
NF-κB controlled promoter [47].
The acetylation targeted lysine K346 is part of the 20
C-terminal amino acids of Tax, which have been
directly implicated in Tax transforming activity. This
region includes the PBM motif involved in Tax inter-
action with PDZ domain-containing proteins [33,34]
and a domain involved in genomic instability as
evidenced by micronuclei formation [48,49]. In this
work, we demonstrate that K346 acetylation controls
the ability of Tax to transform Rat-1 fibroblasts in the
well-established model of colony formation in soft
agar. Transformation of Rat-1 fibroblasts by acetylated
Tax correlates with stimulation of the kinase activity
of CDK4-cyclin D3-p21CIP complex, leading to pRb
phosphorylation.Results
Two acetylated forms of Tax are detected in various
cell lines expressing Tax, including HTLV-1 infected
T lymphocytes
Acetylation of a lysine residue modifies the isoelectric
pH of proteins. Consequently, we used two-dimensional
gel electrophoresis followed by Western Blotting (2D-
Western) to identify the acetylated forms of Tax in
lysates of 293T cells (Figure 1A and 1B) or T lymphocyte
cell lines expressing Tax (Figure 1C). A monoclonal anti-
body (mAb) directed against Tax (anti-Tax) and a newly
developed rabbit polyclonal antibody directed against
the form of Tax acetylated at K346 (anti-AcK346Tax) were
used to detect the various forms of Tax. Detection using
the anti-Tax antibody revealed four species of molecular
mass 40 kDa in cells expressing wild type (WT) Tax (an-
notated 1, 2, 3 and 4). Among them, the two barely
detected forms (2 and 4) were detected in WT Tax but
not in K346R mutant expressing cells. When the same
samples were analyzed by 2D-Western with the anti-
AcK346Tax antibody, two species of Tax were detected in
WT Tax expressing cells, but no form of Tax was
detected in cells expressing mutant K346R. The align-
ment with an internal isoelectric point marker (not
included in the area of gels presented in Figure 1A) indi-
cated that the two acetylated species detected by the
anti-AcK346Tax antibody in WT Tax expressing cells
comigrated with species 2 and 4 detected by the anti-
Tax antibody.
To further characterize the acetylated forms of Tax, WT
Tax was coexpressed with either the acetyltransferase
p300 or the class IIa deacetylase HDAC7 and analyzed by
2D-Western (Figure 1B). Coexpression of p300 with WT
Tax markedly increased the intensity of forms 2 and 4,
whereas coexpression of HDAC7 resulted in the dis-
appearance of these two acetylated forms. Coexpression of
HDAC5, another class IIa deacetylase also led to reduced
acetylation of Tax, contrary to coexpression of the class
IIb deacetylase HDAC6 (data not shown). Furthermore,
treatment of Tax expressing 293T cells with the deacetylase
inhibitor Trichostatin A (TSA) resulted in a two fold in-
crease of Tax acetylation (Additional file 1).
It is worthwhile noting that the two more acidic
species of Tax detected by 2D-Western using the anti-
Tax antibody (species 3 and 4) are phosphorylated, as
indicated by metabolic labeling with 32P orthophosphate
(Additional file 2). Thus, separation of the modified
forms of Tax by 2D-Western revealed four different
40 kDa species including a non-modified form (NM,
form 1), an acetylated form (Ac, form 2), a phosphory-
lated form (P, form 3) and an acetylated and phos
phorylated form (Ac/P, form 4), with estimated per-
centages of NM 46%, Ac 3%, P 50% and Ac/P 1%
(Additional file 2).
Figure 1 Two acetylated forms of Tax are detected in various
cell lines expressing Tax, including HTLV-1 infected T
lymphocytes. Extracts from 293T cells expressing WT Tax or the
K346R mutant (A), WT Tax and either p300-HA or HDAC7-Flag (B), or
JPX9 T lymphocytes either induced for Tax expression with CdCl2 (I)
or not induced (NI) and HTLV-1 infected T lymphocyte cell lines
C8166 and MT4 (C), were analyzed by two-dimensional gel
electrophoresis followed by Western Blotting with anti-Tax and
anti-AcK346Tax antibodies. M, internal pH marker; NM, non-modified;
P, phosphorylated; Ac, acetylated; P/Ac, phosphorylated and
acetylated. Acetylated forms are highlighted by arrows.
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lated forms of Tax were also present in T lymphocyte cell
lines expressing Tax. JPX-9 cells, that express Tax after
induction with CdCl2, or HTLV-1 infected T lymphocyte
cell lines, C8166 and MT4 were analyzed by 2D-Western(Figure 1C). Each of these cell lines contained the Ac and
Ac/P forms of Tax, in addition to the NM and P forms.
The MT4 cell lines also expressed additional forms that
did not comigrate with the NM, Ac, P and Ac/P forms
identified above, possibly due to the presence in this cell
line of multiple proviruses that express variant Tax
proteins.
Acetylation of Tax is modulated by p300 and HDAC7 in
the Tax nuclear bodies
Our previous studies indicated that both WT Tax and the
acetylation deficient K346R mutant had similar intracellular
distribution and colocalized with the acetyltransferase
p300 in Tax NBs. In addition, cellular fractionation indi-
cated that the acetylated form of Tax was predominantly
localized in the nucleus, suggesting that the acetylated
form of Tax could be present in the Tax NBs [47]. To dir-
ectly test this possibility, HeLa cells expressing WT Tax or
the K346R mutant were analyzed by immunofluorescence
staining and confocal microscopy with the anti-AcK346Tax
antibody (Figure 2A). Since overexpression of p300 in-
creased the amount of the acetylated forms of Tax,
whereas overexpression of HDAC7 resulted in the dis-
appearance of these forms (see above), we included cells
that coexpressed WT Tax or the K346R mutant with either
p300-HA (Figure 2B) or HDAC7-Flag (Figure 2C). The
intensity profiles of the immunofluorescence staining
along lines drawn across the nuclei are shown.
Endogenous p300 had a speckled distribution in the
nucleoplasm of cells in the absence of Tax expression.
Expression of Tax confirmed the formation of Tax NBs
containing endogenous p300 in WT Tax and mutant K346R
expressing cells [47,50]. Interestingly, anti-AcK346Tax anti-
body detected the acetylated form of Tax in the Tax NBs
formed by WT Tax, whereas no staining was observed in
the Tax NBs assembled by mutant K346R (Figure 2A).
Cytoplasmic Tax molecules that accumulated at the
boundary of the nuclear envelope were detected only by
anti-Tax and not by anti-AcK346Tax antibody in both wild
type and mutant K346R expressing cells.
Overexpressed p300-HA concentrated in the Tax NBs
and markedly increased the intensity of the anti-AcK346Tax
fluorescence staining in the Tax NBs formed by WT Tax
as shown by the intensity profiles in Figure 2A (WT)
and Figure 2B (WT + p300-HA). Staining intensity was
at background level in mutant K346R expressing cells.
Overexpressed HDAC7-Flag (or HDAC5-Flag, data not
shown) had a rather diffuse distribution in the nucleo-
plasm in cells that did not express Tax and concentrated
in the Tax-NBs formed by WT and mutant K346R Tax
(Figure 2C). Concentration of HDAC7-Flag in the Tax
NBs resulted in a marked reduction of the anti-AcK
346Tax fluorescence staining in the Tax NBs. The same
results were obtained when HDAC5-Flag was expressed
Figure 2 Colocalization of Tax with p300 and HDAC7 in the Tax nuclear bodies modulates Tax acetylation status. HeLa cells were
transfected with vectors expressing WT Tax or the K346R mutant alone (A) or with a vector expressing either p300-HA (B) or HDAC7-Flag (C). Cells
were analyzed by triple immunofluorescence staining and confocal microscopy with the anti-Tax IgG2a mAb, the anti-AcK346Tax rabbit polyclonal
antibody and either the anti-p300 IgG1 mAb (A), the anti-HA IgG1 mAb for the detection of overexpressed p300-HA (B) or the anti-Flag IgG1
mAb for the detection of HDAC7-Flag (C). The intensity profiles of the fluorescence staining along lines crossing the nuclei are shown.
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plasmic deacetylase HDAC6 did not colocalize with Tax in
the Tax NBs and had no effect on the level of acetylated
Tax detected in Tax NBs (data not shown). These results
demonstrated that the acetylated forms of Tax were
present in the Tax NB. They also supported the idea that
the acetylation status of Tax was modulated by p300 and
HDAC7/5 in the Tax NBs. Furthermore, WT Tax and the
acetylation deficient mutant K346R were similarly distrib-
uted in cytoplasmic hot spots and in nuclear bodies
and overexpression of p300 or HDAC7, which have
opposite effects on Tax acetylation status (see Figure 1),
did not affect Tax intracellular localization. From theseFigure 3 Acetylation controls Tax-mediated transformation of Rat-1 c
expressing WT Tax or the K346R or K346Q mutants. Cells were plated in soft
activity expressed as the percentages of colonies formed relatively to WT T
(B) Before plating, aliquots of the Rat-1 cells transduced with the lentiviral
with anti-Tax and anti-actin antibodies.observations, we concluded that Tax acetylation status does
not control Tax intracellular localization.
Acetylation controls Tax-mediated transformation of
Rat-1 cells
Lysine K346 is part of the C-terminal domain of Tax in-
volved in Tax transforming activity. We consequently
tested whether acetylation controlled Tax ability to induce
anchorage-independent growth of Rat-1 fibroblasts, a
well-established method to determine Tax transforming
potential. First, based on the previous observation that a
glutamine residue mimics acetylated lysines [51], we
constructed a Tax mutant in which lysine K346 wasells. (A) Rat-1 cells were stably transduced with lentiviral vectors
agar and colonies were counted 6 weeks later. The transforming
ax are the average of 3 independent experiments. ***: p < 0.05.
vectors were lysed and tested for expression of Tax by Western Blot
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K346Q had a distribution very similar to WT Tax or mu-
tant K346R, with concentration in cytoplasmic structures
associated with the Golgi and colocalization with p300 in
nuclear bodies. As expected, this mutant was not detected
by the anti-AcK346Tax antibody (data not shown). Then,
Rat-1 cells were stably transduced with either lentiviral
control vector (Rat/LV) or lentiviral vectors expressing
WT Tax (Rat/LV-WT), mutant K346R (Rat/LV- K346R) or
mutant K346Q (Rat/LV-K346Q).
FACS analysis was used to determine that about 75%
of the transduced Rat-1 cells expressed WT Tax or
K346R or K346Q after 7 days of culture in the presence
of 10 μg/ml of blasticidin (data not shown). The cells
were plated in soft agar and the number of colonies
formed after 6 weeks was estimated (Figure 3A).
Aliquots of the transduced Rat-1 cells were also tested
for expression of WT or mutant Tax (Figure 3B). The
percentage of anchorage-independent colonies formed by
Rat/LV-K346R was only 20% as compared to Rat/LV-WT,
whereas Rat/LV-K346Q formed anchorage-independentFigure 4 Activation of the NF-κB and ATF/CREB pathways in Rat-1 cel
the control lentiviral vector (−) or with the lentiviral vector expressing wild
0.5 μg HTLV-1 LTR-luc (white bars) reporter constructs and 0.5 μg of pRL-TK
Rat-1 cells expressing Tax relatively to control Rat-1 cells. The values are av
The numbers above the bars represent basal luciferase activities in control
were analyzed by triple immunofluorescence staining with anti-Tax IgG2a m
followed by confocal microscopy.colonies at the same rate as Rat/LV-WT Tax. Quantitation
of WT or mutant Tax expressed in the transduced Rat-1
cells indicated that the reduced transformation rate of
Rat/ LV-K346R did not result from reduced expression
of this mutant. In addition, the Tax nucleotide sequence
of three transformed Rat/LV-WT, Rat/LV-K346R and
Rat/LV-K346Q clones was determined to assure the
correct WT or mutated sequence at residue 346. We
concluded that acetylation controls Tax transforming
activity in Rat-1 fibroblasts.
Transformation of Rat-1 cells does not depend on
Tax-mediated activation of the NF-κB pathway
Activation of the NF-κB pathway is one of the Tax
functions critical for cellular transformation [52,53].
Therefore, we tested the ability of Tax to activate the
NF-κB pathway in the Rat/LV-WT cells by transfec-
tion of a κB-luc reporter construct. Tax-mediated
activation of the HTLV-1 promoter via the ATF/CREB
pathway was also tested as a control for Tax tran-
scriptional activity by transfection of the HTLV-1ls expressing wild type Tax. (A) Rat-1 cells transducted with either
type Tax (Tax) were transfected with 0.5 μg of κB-luc (grey bars) or
-luc. The results are presented as fold increase of luciferase activities in
erages of three independent experiments, with standard deviations.
Rat-1 cells. (B) Control Rat-1 cells (−) or Rat-1 cells expressing Tax (Tax)
Ab, anti-RelA rabbit polyclonal antibody and anti-p300 IgG1 mAb
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expressed in the Rat-1 transduced cells was unable to
increase basal NF-κB activity although it increased
activation of transcription initiated at the HTLV-1
LTR by a factor of 6. Interestingly, comparison of the
luciferase activities resulting from activation of the
NF-κB and ATF/CREB pathways in control Rat-1 cells
(974 versus 13 light units) strongly suggested that the
NF-κB pathway was constitutively activated in Rat-1
cells, independently of Tax expression. To test this
possibility, we checked whether the RelA subunit of
NF-κB was present in the nuclei of Rat-1 cells that
did not express Tax, by using immunofluorescence
staining and confocal microscopy. The images
presented in Figure 4B clearly indicated the RelA was
present in the nuclei of Rat-1 cells. Expression of Tax
in these cells resulted in the colocalization of RelA
and p300 in the Tax NBs, like previously observed
[47], but did not alter the level of RelA already
present in the nuclei. Thus, transformation of Rat-1
cells appears to be independent of Tax-mediated
NF-κB activation, but might depend on constitutive
activation of the NF-κB pathway in these cells. This
observation strongly suggests that the previously
described 50% reduction in activation of a NF-κB-
controlled promoter integrated in the chromatin by
mutant K346R [47] cannot justify the loss of
transforming activity of this mutant.Acetylation does not control the interaction of Tax with
the PDZ domain-containing proteins, hDLG
Since the acetylation targeted lysine K346 lies close to
the PBM (E350TEV353), which controls Tax interaction
with hDLG and contributes to Tax transforming
activity [33,34], we asked whether Tax acetylation had
consequences on the interaction of Tax with hDLG.
293T cells were cotransfected with vectors for expres-
sion of either WT Tax or the K346R mutant and a
vector expressing HA-hDLG. Western Blot analysis of
cells lysates immunoprecipitated with anti-Tax
revealed that both mutant K346R and WT Tax associ-
ated with hDLG (Figure 5A). We also tested the
intracellular localization of WT Tax or the K346R
mutant in 293T cells overexpressing HA-hDLG by im-
munofluorescence staining and confocal microscopy
(Figure 5B). Overexpressed HA-hDLG had a rather dif-
fuse distribution in the cytoplasm and coexpression of
WT Tax or the K346R mutant with HA-hDLG led to
the redistribution of both WT or mutant Tax and
HA-hDLG to cytoplasmic speckled structures, in which
they colocalized. These results support the conclusion
that the interaction of the Tax PBM motif with hDLG is
not regulated by the acetylation status of Tax.Acetylation controls the ability of Tax to stimulate
phosphorylation of pRb by CDK4-cyclin D3-p21
complexes
Tax-mediated activation of the pRb kinase activity of
CDK4/6-cyclin D3-p21CIP complexes contributes to cell
transformation by accelerating cell cycle progression at
the G1 to S restriction point [26-30]. We thus asked
whether Tax acetylation was involved in activation of the
pRb kinase activity of these complexes. First, we tested
the experimental conditions that led to increased pRb
kinase activity of CDK4-cyclin D3 complexes in the
presence of Tax (Figure 6A). Intracellular CDK4-D-type
cyclin complexes are predominantly associated with
CDK inhibitors (CKI) p21 or p27. At low stoichiometric
binding ratio, p21 favors formation of active CDK4-
cyclin D3 complexes, but higher stoichiometric ratios of
p21 binding inhibit CDK4 activity [54-57].
The formation and the kinase activity of the CDK4-
cyclin D3-p21 complexes were tested in CHO cells
cotransfected with vectors expressing WT Tax-HA,
CDK4, cyclin D3 and either low dose (0.2 μg) or high
dose (2 μg) of vector expressing p21. The cell extracts
were immunoprecipitated with an anti-cyclin D3 mAb
and subsequently analyzed by Western Blotting using
anti-cyclin D3, anti-CDK4, anti-p21 and anti-HA antibodies
to determine the composition of the immunoprecipitated
complexes. These complexes were then assayed in vitro
for phosphorylation of a pRb fragment containing threo-
nine 826, a known target of CDK4. The diagram of
Figure 6A represents the relative CDK4 specific kinase
activity calculated by estimating the quantity of phosphor-
ylated pRb fragment on the Western Blot reported to
equal amount of CDK4 in the complexes.
Expression of p21 in the absence of Tax resulted in
stabilization of CDK4-cyclin D3 complexes, in a p21 dose-
dependent manner. The specific CDK4 kinase activity of
these complexes (grey bars) was reduced by factors 2 and
25 when the complexes were formed in the presence of
low or high dose of p21, respectively. These results are in
accordance with the reported consequences of p21 dosage
on stabilization and inhibition of CDK4-cyclin D3 com-
plexes [56-58]. Stabilization of the CDK4-cyclin D3 com-
plexes in a p21 dose-dependent manner was also observed
in the presence of Tax and these complexes included Tax.
However, these complexes had a kinase activity (white
bars) that was markedly higher than that of the complexes
assembled in the absence of Tax, when high dose of p21
was expressed (8.6 fold increase). Expression of Tax in the
absence or with a low dose of p21 gave kinase activities
similar to that in the absence of Tax. These results indicate
that inclusion of Tax in the CDK4-cyclin D3-p21 com-
plexes partly relieves the inhibitory action of p21 on the
pRb kinase activity of the complexes. These results are in
accordance with previous observations [27,28].
Figure 5 Acetylation does not prevent interaction of the Tax with PDZ-binding protein hDLG. (A) 293T cells transfected with vectors
expressing HA-hDLG and WT Tax or mutant K346R were subjected to anti-Tax immunoprecipitation (IP Tax) and analyzed by Western Blotting with
anti-HA antibody. Total lysates were analyzed by Western Blotting with anti-Tax and anti-HA antibodies. (B) 293T cells expressing WT Tax or the
K346R mutant alone or with HA-hDLG were analyzed by immunofluorescence staining and confocal microscopy with anti-Tax IgG2a mAb and
anti-HA rabbit polyclonal antibody for the detection of HA-DLG.
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Figure 6 Acetylation controls the ability of Tax to stimulate phosphorylation of pRb by CDK4-cyclin D3-p21CIP complexes. CHO cells
were transfected with vectors expressing CDK4, cyclin D3 and either 0.2 or 2 μg of vector expressing p21 with or without a vector expressing
Tax-HA (A), or 2 μg of vector expressing p21 with vectors expressing WT or mutant K346R or K346Q Tax-HA (B), or 2 μg of vector expressing p21
and WT Tax-HA and 1 or 2 μg of vector expressing HDAC7-Flag (C). Total lysates were immunoprecipitated with the anti-cyclin D3 mAb and
both the total lysates and the immunoprecipitated complexes (IP anti-cyclin D3) were analyzed by Western Blotting using antibodies shown on
the left side of the lanes. The immunoprecipitated complexes were also analyzed using an in vitro pRb phosphorylation assay. The diagrams
represent the relative CDK4 specific activity obtained by quantitation of the intensity of the pRb phosphorylated species on the blots reported to
equal amount of CDK4 in the complexes. One representative experiment is presented in panel A. Error bars were calculated for two independent
experiments in panels B and C.
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quences on the formation and kinase activity of the com-
plexes. CHO cells were cotransfected with vectors
expressing CDK4, cyclin D3, the high dose (2 μg) of vector
expressing p21 and vectors expressing either WT Tax, the
non-acetylated K346R mutant or the acetylation mimetic
K346Q mutant (Figure 6B). Both mutants K346R and K346Q
associated with the complexes, but the specific kinase ac-
tivity of the complexes containing mutant K346R was de-
creased by a factor 2 as compared to complexes containing
WT Tax or the acetylation mimetic K346Q mutant.
To further analyze the role of Tax acetylation in sti-
mulation of CDK4 kinase activity, we tested whether
overexpression of HDAC7, which strongly deacetylates
Tax, had consequences on the ability of the CDK4-cyclin
D3-p21-Tax complexes to phosphorylate pRb (Figure 6C).
Expression of HDAC7 had no consequences on the for-
mation of the CDK4-cyclin D3-p21-Tax complexes, but
reduced the ability of these complexes to phosphorylate
pRb in a dose-dependent manner. These results indi-
cated that acetylation deficiency did not prevent the
association of Tax with CDK4-cyclin D3-p21 complexes,
but resulted in a reduced capacity of these complexes to
bypass p21 inhibition.
Phosphorylation of pRb results in the release of tran-
scriptionally active free E2F. To further examine the
mechanism involved in Tax acetylation-dependent trans-
forming activity, we analyzed the luciferase activity of
the E2F controlled p3xE2F-luc reporter construct in
CHO cells transfected with the plasmids expressing
CDK4, cyclin D3 and p21 and either WT Tax or theFigure 7 Acetylation controls Tax-mediated release of free E2F.
CHO cells were transfected with 250 ng of p3xE2F-WT-luc reporter
construct and 100 ng of pRL-TK-luc, 50 ng of vectors expressing
cyclin D3 and CDK4 alone or in combination with vectors expressing
p21 (100 ng), and either WT Tax or the K346R or K346Q mutants
(600 ng). The results are presented as fold increase of luciferase
activities. The values are averages of three independent experiments,
with standard deviations indicated.K346R or K346Q mutants like reported in Figure 6B.
Figure 7 indicates that activation of the E2F controlled
promoter was reduced following expression of p21 and
that WT Tax expression resulted in the bypass of p21
repression in an acetylation-dependent manner, thus
mimicking the effects observed on pRb phosphorylation.
Discussion
In this work, we have demonstrated that acetylation at
lysine K346 in the C-terminal domain of Tax plays a critical
role in Tax capacity to transform Rat-1 fibroblasts and in
rendering the pRb kinase activity of CDK4-cyclin D3-p21-
Tax complexes resistant to p21 inhibition. These conclu-
sions are based on the observations that the acetylation
deficient K346R mutant, but not the acetylation-mimetic
K346Q mutant, is deficient for both transformation of
Rat-1 fibroblasts and activation of the CDK4 complexes
stabilized by p21.
Here, we identify two acetylated forms of Tax, including
an acetylated and phosphorylated form, that are both
present in fibroblasts overexpressing Tax and in HTLV-1
infected T lymphocytes. The fraction of acetylated forms
was estimated at about 4 percent of all four 40 kDa Tax
species. This low percentage clearly has physiological sig-
nificance since we demonstrate that loss of Tax acetylation
results in markedly reduced transforming activity. It is
now well recognized that the biological consequences of
modified forms are not proportional to the small fraction
of substrate that is modified [59]. It is also worth noting
that the acetylated Tax forms are concentrated in the Tax
NBs, along with a variety of effectors including the
acetyltransferase p300 and the deacetylase HDAC7, which
might compete to regulate Tax acetylation status in a
dynamic process. Finally, the presence of acetylated Tax in
the Tax NBs supports our previous observation using cell
fractionation experiments indicating that acetylated Tax is
essentially distributed in the nucleus [47]. The contribu-
tions of each acetylated form to the transformation pheno-
type and determination of the phosphorylated residue
need further investigations.
In addition to consequences on pRb phosphorylation,
our previous studies indicated that acetylated Tax favored
activation of a NF-κB controlled promoter, when the re-
porter construct was integrated in the chromatin [47].
Our results suggest that the transformation phenotype
observed in Rat-1 cells does not depend on Tax ability
to activate gene expression from a κB-controlled pro-
moter but might depend on constitutive NF-κB activa-
tion in Rat-1 cells.
How does Tax acetylation alter the kinase activity
of CDK4?
Mechanistically, acetylation of Tax acts on stimulation of
the pRb kinase activity of CDK4-cyclin D3-p21 complexes
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activation of an E2F-controlled promoter. However,
acetylation was dispensable for the association of Tax with
the CDK4-cyclin D3-p21 complexes. This concept is
supported by the observations that WT Tax as well as
mutants K346R and K346Q were associated with the
CDK4-cyclin D3-p21 complexes, and that WT Tax or the
acetylation-mimetic K346Q mutant were more potent in
preventing the inhibitory action of the CDK inhibitor p21
and in increasing transcription from the E2F-controlled
promoter than the acetylation deficient K346R mutant. In
addition, expression of the deacetylase HDAC7, which
markedly reduced Tax acetylation, did not affect the asso-
ciation of Tax with the complexes, but prevented stimula-
tion of the pRb kinase activity of the complexes by WT
Tax, in a dose-dependent manner.
It will be important to determine how acetylation of
Tax acts to prevent the inhibitory action of p21. Binding
of p21 through both its cyclin-binding motif (Cy1) and
its CDK-binding motif (K) is required for inhibition of
the kinase activity of the CDK4-cyclin D complex [60].
Previous studies indicated that the N-terminal 40 amino
acids of Tax directly interact with the PSTAIRE N-
terminal domain of CDK4 and that Tax also interacts with
cyclin D3. Most likely, one of these interactions might
affect the binding of p21 through one of its cyclin/CDK
interaction motifs. Tax interaction would thus allow the
stabilization by p21 of abundant CDK4-cyclin D3
complexes that remain partially active despite high p21
expression levels, leading to enhancement of both phos-
phorylation of pRb and steady state level of free E2F,
with subsequent acceleration of progression from the
G1 to the S phase of the cell cycle [27,28]. In addition,
Tax stimulates expression of p21 at the transcriptional
level in fibroblasts overexpressing Tax and in HTLV-1
infected T lymphocytes [61,62], and induces phosphor-
ylation of cyclin D3 [26]. Importantly, our results indi-
cate that lack of acetylation does not affect the ability of
Tax K346R to associate with CDK4-cyclin D3-p21 com-
plexes. The K346 acetylated C-terminal domain of Tax
might recruit a kinase involved in phosphorylation of crit-
ical residues of the CDK4-cyclin D3-p21 complex such
as threonine 172 in the CDK4 activation loop [58]. Alter-
natively, since an extensive number of kinases regulate
CKIs to control their function, localization and stability
[63], one could speculate that Tax recruits a kinase in-
volved in the control of p21 inhibitory function.
Previous studies indicated that, in T lymphocytes cell
lines and HTLV-1 infected lymphocytes, but not in fibro-
blasts, Tax activates cyclin D2 and CDK6 promoters via
activation of the NF-κB pathway resulting in cell cycle
progression [64]. In addition, stable p21-cyclin D2-CDK4
complexes active in phosphorylation of pRb were detected
in HTLV-1 infected T cells [65]. Further studies will beimportant to determine whether Tax acetylation also con-
trols cell cycle progression in T-cells and whether the ac-
tivity of different complexes such as p21-cyclin D2-CDK6
are modulated by Tax acetylation in T cells.How does Tax C-terminal region function in cellular
transformation?
The acetylation targeted lysine K346 is part of the C-
terminal domain of Tax that otherwise contains two
critical functions participating in Tax transforming poten-
tial. These include the four C-terminal amino acids which
form a PBM motif for interaction with the hDLG and
hScrib and MAGI-1 tumor suppressors [11,31,33,34], and
a region involved in micronuclei formation [48,66]. Here
we show that the lack of acetylation of the K346R mutant
does not affect its ability to interact with hDLG or to be
redistributed by hDLG into cytoplasmic speckles. We con-
clude that activation of the kinase activity of CDK4-cyclin
D3-p21 complexes by acetylated Tax and interaction with
hDLG are distinct functions that both participate in Tax
transforming activity, in a necessary, but not sufficient
manner.
Comparison of the transforming activities of the Tax
proteins of HTLV-1 (Tax-1) and HTLV-2 (Tax-2), which
markedly differ in pathogenicity, might reveal information
about the role of the C-terminal domain in Tax-induced
transformation. The weakly transforming Tax-2 protein
shares a high degree of amino acid similarity with Tax-1,
but the two proteins have divergent C-terminal domains.
In addition, Tax-2 does not include a functional PBM and
does not induce micronuclei formation [67]. Furthermore,
the chimera formed by fusion of the C-terminal domain of
Tax-1 to the C-terminus of Tax-2 displays increased cap-
acity to promote proliferation of human PBMCs as com-
pared to Tax-2 [34,68]. Studies are underway to determine
whether the acetylation status of Tax-2 concurs with the
absence of a PBM to determine its reduced transforming
activity.How do Tax NBs function in cellular transformation?
Tax NBs control two central functions in Tax transforming
activity. These include activation of gene expression via
the NF-κB pathway [39,40], and sequestration of effectors
involved in DNA repair [24,25]. Our finding showing that
the acetylated forms of Tax and the enzymes that modu-
late Tax acetylation are concentrated in Tax NBs, incrimi-
nates these structures in both Tax acetylation and
transforming activity. This conclusion is also supported by
our previous observation that mutants deficient for
sumoylation and subsequent assembly of the Tax NBs
have a markedly reduced acetylation status [47]. These
results support the idea that transformation by Tax is
the consequence of a cascade linking Tax sumoylation-
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kinase CDK4 for cell cycle progression.
Conclusions
Is deacetylase therapy appropriate for ATL?
Our work questions whether treatments of ATL patients
with drug regimens that include inhibitors of deacetylases
are appropriate since such treatments could theoretically
increase Tax acetylation [69,70]. It will be important to
determine if Tax acetylation promotes transformation of
HTLV-1 infected T lymphocytes and if HDAC inhibitors
stimulates Tax acetylation in T-cells. Determination of the
actual enzymes that regulate Tax acetylation in HTLV-1
infected patient samples would provide new therapeutic
targets for the treatment of HTLV-1 infected patients who
present a risk of developing ATL.
Methods
Cell culture and transfection
293T, 293GP2, HeLa and Rat-1 cells were maintained in
Dulbecco’s modified Eagle’s medium (DMEM), and CHO
cells were maintained in F12 HAM medium, which were
supplemented with 2 mM L-Glutamine, 10% fetal calf
serum (FCS), 1% penicillin-streptomycin and 1 mM so-
dium pyruvate (Life technologies, Paisley, UK). Cell lines
were transfected using the Transit LT-1 reagent (Mirus
Bio LLC, Madison, USA) according to the manufacturer’s
instructions. The HTLV-1 infected T lymphocyte cell lines
C8166 and MT4 were maintained in RPMI medium with
Glutamax-I (Life technologies, Paisley, UK) supplemented
with 10% FCS. Expression of Tax by JPX9, a derivative of
Jurkat cells containing an inducible tax gene under the
control of the metallothionein promoter, was induced by
supplementing 30 μM CdCl2 to the RPMI medium for
16 h [71]. Trichostatin A (TSA) was purchased from
Sigma-Aldrich (Belgium).
Expression vectors
The vectors for expression of WT or K346R Tax mutant
and p300-HA were previously described [47], as well
as vectors for expression of CDK4 and cyclin D3 [58].
Mutant K346Q was generated by PCR based site-directed
mutagenesis. Vector for expression of HA-hDLG was pro-
vided by L. Banks [72], HDAC7-Flag was from F. Dequiedt
[73], and p21CIP (referred to as p21) was from L. Hengst
(Innsbruck). The luciferase reporter constructs κB-luc
(Promega), HTLV-1-LTR-luc [39], and p3xE2F-luc [74]
were used in luciferase assays.
Transformation of Rat-1 fibroblasts in soft agar
For lentiviral vector construction, WT, K346R and K346Q
Tax coding sequences were inserted into the pCSEF-IRES-
bsd lentiviral vector kindly provided by M. Fujii [11]. This
generated the pCSEF-IRES-bsd control, pCSEF-Tax WT,pCSEF-Tax K346R and pCSEF-Tax K346Q lentiviral vectors,
which were transfected in 2 × 106 293GP2 packaging cells
together with pCAG-HIVgp and pCMV-VSV-G-RSV-Rev
to produce viral particles. Production of lentiviral vectors
expressing Tax, stable transduction of Rat-1 cells and
transformation assays have been described [20].Antibodies
The antibody recognizing the K346 acetylated form of Tax
was obtained by immunizing rabbits with a synthetic pep-
tide (H2N-CEPPSEK(Ac)HFRET-CONH2). Specific anti-
bodies were enriched by selection against both the
acetylated and the non-acetylated peptides (Eurogentec, Se-
raing, Belgium). The specificity of the purified antibody was
tested by ELISA (Additional file 3). The mouse IgG2a anti-
Tax-1 mAb from hybridoma 168-A51 was obtained from
the AIDS Research and Reagent Program, National Insti-
tutes of Health (Bethesda, MD, USA). Anti-p300 (RW-128)
was from Upstate (Massachusetts, USA). Anti-CDK4 (H-
22), anti-cyclin D3 (DSC-28), anti-RelA (C-20) and anti-
p21 (C-19) antibodies were from Santa Cruz Biotechnolo-
gies (California, USA). Anti-actin, anti-Flag (M2) and the
biotinylated anti-HA antibodies were from Sigma (St.
Louis, USA). Anti-phospho T826 pRb antibody was from
Abcam (Cambridge, UK). The secondary antibodies used
for immunofluorescence staining were Dylight 488-
conjugated goat anti-mouse IgG2a, Dylight 549- or 488-
conjugated goat anti-rabbit IgG and Dylight 649-
conjugated goat anti-mouse IgG1 from Jackson
ImmunoResearch (Pennsylvania, USA).Luciferase activities
Tax-mediated transactivation of genes expression via the
NF-κB and ATF/CREB pathway was evaluated by dual
luciferase assays using of the transfected κB-luc and
HTLV-1-LTR-luc reporter constructs respectively. Rat-1
cells (1 × 105) transducted with either the control
lentivirus or with the lentivirus expressing wild type Tax
were transfected into 12-well plates with 500 ng of
pRL-TK-luc (Promega), used for monitoring transfection ef-
ficiency, and either 500 ng of κB-luc or 500 ng of
HTLV-1-LTR-luc reporter plasmids. 24 h after transfection,
cells were lysed and subjected to luciferase assay with the
dual luciferase reporter assay system (Promega) and a TD-
20/20 luminometer (Turner Designs) according to protocol
of the manufacturer. For E2F luciferase assays, CHO cells
were transfected with 250 ng of p3xE2F-WT-luc and
100 ng of pRL-TK-luc reporter plasmids, and vectors ex-
pressing cyclin D3 and CDK4 (50 ng each). The effects of
p21 CDK inhibitor and WT Tax or K346R or K346Q mutants
on activation of the E2F-controlled promoter were assessed
by cotransfection of p21 (100 ng) and Tax (600 ng) expres-
sion vectors.
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Cells were lysed in lysis buffer containing 7 M urea, 2 M
thiourea, 40 mM DTT, 4% (w/v) CHAPS and deacetylase,
protease and phosphatase inhibitors (0.5 μM TSA and
5 mM NAA, complete EDTA-free and Phosphostop from
Roche Diagnostics GmbH, Mannheim, Germany). Immu-
noglobulins (0.4 μg) were used as internal pH markers and
added to the sample before loading. Proteins were sepa-
rated by isoelectric focusing using the Ettan IPGphor3
apparatus from GE Healthcare (Buckinghamshire, UK)
and active in-gel rehydratation of pH5-8 IPG strips as de-
scribed in manufacturer’s protocol (BioRad, California,
USA). After isoelectric focusing, the IPG strips were
loaded onto 4-12% Bis-Tris NuPAGE gel (Life technolo-
gies, Paisley, UK) for separation according to molecular
mass. Methods for second dimension electrophoresis and
Western Blotting have been described [47].
Co-immunoprecipitation and in vitro pRb
phosphorylation assay
Co-immunoprecipitation and in vitro pRb phosphoryl-
ation assay were performed according to [58]. Briefly, cells
were lysed in buffer containing 150 mM NaCl, 50 mM
Tris–HCl pH 7.5, 0.5% Nonidet P-40, 50 mM NaF, 1
mM sodium orthovanadate, 1 mM β-glycerophosphate,
10 mM DTT, protease inhibitors (complete EDTA-free,
Roche Diagnostics GmbH, Mannheim, Germany), and
10% glycerol. The homogenized cellular lysates were
cleared and incubated at 4°C for 3 h with protein A seph-
arose 4 fast flow that had been preincubated overnight
with 2 μg of the antibody used for immunoprecipitation.
Immunoprecipitated complexes were resuspended in kin-
ase reaction buffer (50 mM HEPES, pH 7.5, 10 mM KCl,
10 mM MgCl2, 2.5 mM EGTA, 1 mM DTT) containing
2 mM ATP, 0.5 μg of a pRb fragment (amino acids 773–
928) (Sigma, St. Louis, USA), 10 mM β-glycerophosphate,
0.1 mM orthovanadate, 1 mM NaF, protease inhibitors
(complete EDTA-free, Roche Diagnostics GmbH, Mann-
heim, Germany), and incubated for 30 min at 30°C.
Immunoprecipitated complexes and kinase assays were
separated on 4-12% Bis-Tris NuPAGE gel (Life technolo-
gies, Paisley, UK) and analyzed by Western Blotting. The
detection was performed using the ECL Advance Western
Blotting detection kit (GE Healthcare, Buckinghamshire,
UK) and quantitation of chemiluminescent signals was
performed with the Chemi-Smart 5000 apparatus and Bio-
1D software (Vilber Lourmat, Marne-la-Vallée, France).
Immunofluorescence and confocal microscopy
Cells were grown on glass coverslips and fixed with
immunohistofix (Gentaur, Kampenhout, Belgium) for
10 min at room temperature (RT) followed by methanol
for 6 min at −20°C and further processed as described
previously [39].Additional files
Additional file 1: Treatment of Tax expressing cells with HDAC
inhibitor TSA increases Tax acetylation. 293T cells expressing Tax were
treated for 18 h with TSA at the indicated concentrations and analyzed
by Western Blotting using anti-Tax, anti-AcK346Tax and anti-actin
antibodies. The numbers under the blots represent relative quantities of
each Tax species normalized to equal amount of actin.
Additional file 2: Detection of phosphorylated forms of Tax. 293T
cells were transfected with a vector expressing WT Tax and metabolically
labeled with 32P orthophosphate. The cell extracts were separated by
two-dimensional gel electrophoresis and analyzed by Western Blotting
with the anti-Tax mAb and autoradiography. Quantitation of the NM
(non-modified), Ac (acetylated), P (phosphorylated) and Ac/P (acetylated
and phosphorylated) species on the anti-Tax immunoblot was done
using Image J software.
Additional file 3: Specificity of anti-AcK346Tax. ELISA was performed
by coating 96-well plates with 100 ng of either the non acetylated
peptide or the acetylated peptide that was used for rabbit immunization.
Serial dilutions of the anti-AcK346Tax antibody (4.6 mg/ml) followed by
anti-rabbit-HRP were incubated for 2 hours. The substrate was incubated
for 30 min and the reaction was stopped with 4 M H2SO4, followed by
optical density measurements at 492 nm.
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